title: Comparison of a quantitative PCR method with FISH for the assessment of the four aneuploidies commonly evaluated in CLL patients.
abstract: Four chromosomal defects associated with outcome are commonly evaluated by fluorescent in situ hybridization (FISH) in chronic lymphocytic leukemia (CLL), namely deletions of the 13q13-q14, 11q22 and 17p13 regions and trisomy 12. In this study, we compared a quantitative PCR method--quantitative multiplex PCR of short fluorescent fragment (QMPSF)--with FISH for the detection of these acquired aneuploidies in a series of 110 patients with Binet stage A CLL. Genes located in the deleted or gained regions were selected as target genes and amplified using a method based on the simultaneous amplification of short fluorescent genomic fragments under quantitative conditions. A chromosomal imbalance involving one or several of the four loci was detected by either method in 72 patients (65%). A chromosome 13 deletion was present in 61 patients (54%), a 11q22 deletion in nine (8%), a trisomy 12 in nine and a 17p deletion in one. FISH and QMPSF results were identical for 103 out of 110 patients and discrepancies could be explained in most cases. This study demonstrates that a quantitative multiplex PCR represents a cost-effective method that could replace FISH in CLL patients. However, although QMPSF is perfectly adapted to the detection of primary defects, care should be taken when searching for clonal evolutions present in a small proportion of tumor cells.
authors.affiliation: Groupe d'Etude des Proliférations Lymphoïdes, Centre Henri Becquerel, Rouen, France. christian.bastard@rouen.fnclcc.fr
authors.forename: C
authors.initials: C
authors.lastname: Bastard
authors.forename: G
authors.initials: G
authors.lastname: Raux
authors.forename: C
authors.initials: C
authors.lastname: Fruchart
authors.forename: F
authors.initials: F
authors.lastname: Parmentier
authors.forename: D
authors.initials: D
authors.lastname: Vaur
authors.forename: D
authors.initials: D
authors.lastname: Penther
authors.forename: X
authors.initials: X
authors.lastname: Troussard
authors.forename: D
authors.initials: D
authors.lastname: Nagib
authors.forename: S
authors.initials: S
authors.lastname: Lepretre
authors.forename: M
authors.initials: M
authors.lastname: Tosi
authors.forename: T
authors.initials: T
authors.lastname: Frebourg
authors.forename: H
authors.initials: H
authors.lastname: Tilly
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000782:Aneuploidy; D002872:Chromosome Deletion; D002880:Chromosomes, Human, Pair 11; D002882:Chromosomes, Human, Pair 13; D002885:Chromosomes, Human, Pair 16; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D017404:In Situ Hybridization, Fluorescence / Q000592:standards*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction / Q000379:methods* / Q000592:standards; D011379:Prognosis; D014314:Trisomy